Not finding it? Sign in to also search OpenAlex live.
-
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access cited by 1 patent
Alba Llop‐Guevara, Sibylle Loibl, Guillermo Javierre Villacampa, Valentina A. Vladimirova, Andreas Schneeweiß, Thomas Karn, +14 more
107citations -
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
Ulrike Anneliese Nitz, Oleg Gluz, Monika Graeser, Matthias Christgen, Sherko Küemmel, Eva‐Maria Grischke, +43 more
93citations -
Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma2023 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Alexander C. J. van Akkooi, Christian U. Blank, Alexander M.M. Eggermont
35citations -
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma2021 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, Michel W.J.M. Wouters, +7 more
29citations -
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Rosa Di Micco, Steffi Hartmann, Maggie Banys‐Paluchowski, Jana de Boniface, Nina Caroline Ditsch, Elmar Stickeler, +23 more
22citations -
Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?2024 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
M. Loo, Layla Andour, Anne E. van Heesewijk, Hendrika M. Oosterkamp, Gerrit‐Jan Liefers, Marieke Evelien Straver
8citations -
1085P Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab followed by index lymph node excision only versus therapeutic lymph node dissection: 24-week results of the PRADO trial
N.M.J. Van Den Heuvel, Irene L. M. Reijers, Judith M. Versluis, Elisa A. Rozeman, Katarzyna Jóźwiak, K.H. Blommers, +14 more
3citations -
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial.
Paolo Giovanni Nuciforo, John Townend, Cristina Saura, E. de Azumbaja, Florentine Hilbers, Anna Manukyants, +13 more
3citations -
National Breast Cancer Surgery Snapshot Study: Breast Cancer Surgery after Neoadjuvant Systemic Therapy in Primary Breast Cancer (MANS Study)2025 Clinical Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Gaëlle Kramer, José H. Volders, Roza C.M. Opperman, Pauline E. R. Spronk, Petrousjka van den Tol, Marie-Jeanne T. F. D. Vrancken Peeters, +8 more
3citations -
1095P Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
Irene L. M. Reijers, Petros Dimitriadis, Alexander Maxwell Menzies, Ellen Kapiteijn, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk, +13 more
2citations -
Predictors of Immediate Therapeutic Lymph Node Dissection Instead of Index Lymph Node After Neoadjuvant Checkpoint Inhibitors: Lessons Learned from the PRADO Trial
Marieke T. Goodijk, Anke M. J. Kuijpers, Lotte L. Hoeijmakers, Dirk Jan Grünhagen, Yvonne M. Schrage, Michel W. J. M. Wouters, +16 more
1citations -
Effect of breast cancer molecular subtype on axillary treatment strategies based on baseline 18F-FDG PET/CT findings2024 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
C. de Mooij, Janine M. Simons, Cristina Mitea, PJ van Diest, Patricia Joan Nelemans, C. Van der Pol, +4 more
0citations -
Update Mammakarzinom 2021 Teil 1 – Prävention und frühe Krankheitsstadien2021 Senologie - Zeitschrift für Mammadiagnostik und -therapie article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Elmar Stickeler, Bahriye Aktas, Annika Sophie Behrens, Erik Belleville, Nina Caroline Ditsch, Peter Andreas Fasching, +21 more
0citations -
Five-year PRADO trial update: surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors2025 European Journal of Surgical Oncology article Medicine Cutaneous Melanoma Detection and Management
M. Goodijk, A.M.J. Kuijpers, Alexander C. J. van Akkooi, Lotte L. Hoeijmakers, Dirk Jan Grünhagen, Yvonne M. Schrage, +7 more
0citations -
17P Impact of body mass index (BMI) on prognostic and predictive value of stromal tumour-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC): A pooled analysis of six neoadjuvant trials2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jenny Furlanetto, Carsten Denkert, Michael Untch, Bruno Valentin Sinn, Bianca Lederer, Andreas Schneeweiß, +9 more
0citations -
The MCP2 and the wrist plus two extensor compartments are the most affected and responsive joints/tendons out of the US7 score in patients with rheumatoid arthritis-an observational study2022 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Annika Franziska Podewski, A. M. Glimm, Imma U. Fischer, George A W Bruyn, Petra Hánová, Hilde Berner Hammer, +6 more
4citations